CLCM
RGNX icon

Crawford Lake Capital Management’s Regenxbio RGNX Stock Holding History

Crawford Lake Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-105,400
Closed -$3.15M – 105
2018
Q1 		$3.15M Buy
+105,400
New +$3.07M 0.67% 41

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Crawford Lake Capital Management's RGNX Position: Q4 2021 in Review

Crawford Lake Capital Management sold out of Regenxbio (RGNX) in Q4 2021, closing a stake of 5,000 shares — an estimated $210K sold.

Crawford Lake Capital Management first reported a position in RGNX in Q1 2018 and held it in 2 quarters. The position peaked at $1.15M in Q1 2018. 172 funds tracked by Wall St. Rank hold RGNX as of Q4 2021.

  • Crawford Lake Capital Management reported no remaining Regenxbio position as of Q4 2021 after selling out during the quarter.
  • Crawford Lake Capital Management sold 5,000 Regenxbio shares in Q4 2021, an estimated $210K.
  • Crawford Lake Capital Management first reported a position in Regenxbio in Q1 2018 and held it in 2 quarters.
  • Crawford Lake Capital Management's Regenxbio position peaked at $1.15M in Q1 2018.
  • 172 funds tracked by Wall St. Rank held Regenxbio as of Q4 2021.

Based on Crawford Lake Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.